Teen Prevention: Prescription Drug Safety and Vaping


How are you Rethinking Prevention?

As the opioid epidemic roils communities and the popularity of vaping is leading to hospitalizations and even deaths, our nation’s schools are feeling the impact. We want young adults to be healthy and make informed decisions, and that starts with prevention education.

With 1 in 4 high school students reporting they've used an e-cigarette in the last 30 days, and 1 in 5 high school seniors reporting that they have misused prescription drugs, reaching students early is more important than ever. Hear from surprise experts with National Institute on Drug Abuse on the expanding and evolving challenges teens are facing when it comes to prescription drug safety and vaping.

Attendees will receive:

  • A certificate for 1 hour of professional development
  • Free access to Prescription Drug Safety for High School Students
  • Your Red Ribbon Week Toolkit complete with extension activities, a case study, a discussion guide, printables and more.

Register for Access

Our Experts

National Institute for Drug Abuse

Dr. Ruben Baler

Dr. Ruben Baler received his Ph.D. in Microbiology and Molecular Biology from the University of Miami, Fl. in 1993. He carried out his postdoctoral training at the National Institute of Child Health and Human Development where he specialized in Molecular Chronobiology. He then moved to the National Institute of Mental Health. In October 2004 he joined the Science Policy Branch in the Office of Science Policy and Communications at the National Institute on Drug Abuse as a Health Scientist. His early publications have focused on the temporal regulation of gene expression in the brain’s clock. Dr. Baler has gathered critical insight from diverse disciplines (e.g., molecular biology, genomics, bioinformatics, neuroscience, evolutionary psychology, and neuroethics), which he combines to advance NIDA’s scientific mission with a specific focus on developing more effective universal prevention interventions.


Kimberley Timpf

Kimberley has more than 25 years of experience in the college alcohol and other drug prevention field. Her expertise lies in program design and development, application of prevention theory in higher education settings, training and instruction, and methods of evaluation. Prior to EVERFI, she worked at both public and private institutions and served multiple terms as the directorate chair for ACPA’s Commission for Alcohol and Other Drug Issues. In her current role, Ms. Timpf helps inform the development of EVERFI’s AOD-related content for both K12 and higher ed. She leverages findings from the latest research and key insights from institution-specific data to assist campuses in identifying and prioritizing prevention activities for their institution.

Brian M
National Institute for Drug Abuse

Brian Marquis

Brian Marquis joined the National Institute on Drug Abuse (NIDA) Office of Science Policy and Communications in January 2001. As the Public Liaison Officer, Mr. Marquis manages all marketing and partnership activities associated with the dissemination of NIDA’s science-based research and information to a vast array of audiences including federal, state, local and non-governmental organizations, educators, public health professionals, and the general public. In his efforts to promote NIDA’s research and resources, he also manages 30 national partnerships for NIDA's National Drug & Alcohol Facts Week. His dedication to NIH and the federal taxpayer has earned him numerous awards including the coveted Healthfinder.gov Hammer Award from the National Partnership for Reinventing Government and the NIH Directors Award. He has a B.S. in Health Education and Family studies from University of Maryland, College Park.